Lazari Capital Management’s Gilead Sciences GILD Stock Holding History

Lazari Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,892	Closed	-$264K	–	190
2026 Q1	$264K	Sell	1,892 -30	-2%	-$4.2K	0.09%	129
2025 Q4	$236K	Buy	1,922 +98	+5%	+$11.9K	0.08%	136
2025 Q3	$202K	Buy	+1,824	New	+$207K	0.07%	151
2025 Q1	–	Sell	-3,463	Closed	-$320K	–	159
2024 Q4	$320K	Sell	3,463 -7,665	-69%	-$690K	0.13%	93
2024 Q3	$933K	Sell	11,128 -11,867	-52%	-$906K	0.4%	46
2024 Q2	$1.58M	Buy	22,995 +2,448	+12%	+$163K	0.71%	28
2024 Q1	$1.51M	Buy	20,547 +17	+0.1%	+$1.31K	0.82%	22
2023 Q4	$1.66M	Buy	20,530 +58	+0.3%	+$4.51K	0.95%	19
2023 Q3	$1.53M	Sell	20,472 -57	-0.3%	-$4.38K	0.92%	23
2023 Q2	$1.58M	Buy	+20,529	New	+$1.64M	0.89%	24

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Lazari Capital Management's GILD Position: Q2 2026 in Review

Lazari Capital Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,892 shares — an estimated $264K sold.

Lazari Capital Management first reported a position in GILD in Q2 2023 and held it in 10 quarters. The position peaked at $1.66M in Q4 2023. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Lazari Capital Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
Lazari Capital Management sold 1,892 Gilead Sciences shares in Q2 2026, an estimated $264K.
Lazari Capital Management first reported a position in Gilead Sciences in Q2 2023 and held it in 10 quarters.
Lazari Capital Management's Gilead Sciences position peaked at $1.66M in Q4 2023.
1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Lazari Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.